Do Cochrane reviews provide useful information to guide policy and practice? the experience of the Cochrane Drugs and Alcohol Group

Epidemiology and Psychiatric Sciences

Volumn 20, Issue 3, 2011, Pages 219-223

  Davoli, M ^a   Amato, L ^a  

^a Public Health Agency of Lazio Region   (Italy)

Author keywords

Alcohol; drug abuse; randomized controlled trial; systematic reviews

Indexed keywords

ADDICTION; ALCOHOLISM; BIBLIOGRAPHIC DATABASE; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INFORMATION SERVICE; LITERATURE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD;

ALCOHOLISM; DATABASES, BIBLIOGRAPHIC; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; INFORMATION SERVICES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 80053088802     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796011000412     Document Type: Review

References (25)

1. Ahmad N, Boutron I, Dechartres A, Durieux P, Ravaud P (2010). Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review. Trials 26, 11-20.
2. Amato L, Davoli M, Vecchi S, Ali R, Farrell M, Faggiano F, Foxcroft D, Ling W, Minozzi S, Chengzheng Z (2011). Cochrane systematic reviews in the field of addiction: What's there and what should be. Drug and Alcohol Dependence 113, 96-103.
3. Australian National Drug Strategy (2006). National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence. Available at http://www.health.gov.au
4. Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, Brugal T, Vicente J, for the COSMO European Group (2006). Drug related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health 16, 198-202.
5. Chalmers I (1998). Systematic reviews: insufficient evidence on which to base medicine. British Journal of Obstetrics and Gynecology 105, 1235-1236. (Pubitemid 28526210)
6. Davoli M, Ferri M (2000). The cochrane review group on drugs and alcohol. Addiction 95, 1473-1474.
7. Dekkers OM, von Elm E, Algra A, Romijn JA, Vandenbroucke JP (2009). How to assess the external validity of therapeutic trials: a conceptual approach. International Journal of Epidemiology 39, 89-94.
8. Delaney A, Bagshaw SM, Ferland A, Laupland K, Manns B, Doig C (2007). The quality of reports of critical care meta-analyses in the Cochrane Database of Systematic Reviews: An independent appraisal. Critical Care Medicine 35, 589-594. (Pubitemid 46148553)
9. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ (2008). What is 'quality of evidence' and why is it important to clinicians? British Medical Journal 336, 995-998. (Pubitemid 351656090)
10. Higgins JPT, Green S (2008). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 [updated September 2009]. The Cochrane Collaboration. Available at http://www.cochrane-handbook.org
11. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, Stevens R (2000). Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. British Medical Journal 320, 537-540. (Pubitemid 30175797)
12. Jørgensen AW, Maric KL, Tendal B, Faurschou A, Gøtzsche PC (2008). Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions BMC. Medical Research Methodology 8, 60. doi:10.1186/1471-2288-8-60.
13. Lang A, Edwards N, Fleiszer A (2007). Empty systematic reviews: hidden perils and lessons learned. Journal of Clinical Epidemiology 60, 595-597. (Pubitemid 46687003)
14. Mandel D, Littner Y, Mimouni FB, Lubetzky R (2006). Conclusiveness of the Cochrane Neonatal Reviews: a systematic analysis. Acta Paediatrica 95, 1209-1212. (Pubitemid 44423184)
15. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007). Epidemiology and reporting characteristics of systematic reviews. Public Library of Science Medicine 4, e78. doi:10.1371/journal.pmed.0040078. (Pubitemid 46495312)
16. Moja LP, Telaro E, D'Amico R, Moschetti I, Coe L, Liberati A (2005) Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study. British Medical Journal 330, 1053.
17. NICE (2006). National Institute of Clinical Excellence Technology Appraisal Guidance 114. Methadone and buprenorphine for the management of opioid dependence. Available at http://www.nice.org.uk
18. Olsen O, Middleton P, Ezzo J, Gøtzsche PC, Hadhazy V, Herxheimer A, Kleijnen J, McIntosh H (2001). Quality of Cochrane reviews: assessment of sample from 1998. British Medical Journal 323, 829-832. (Pubitemid 32973609)
19. Pagliaro L, Bruzzi P, Bobbio M (2010). Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making? Digestive and Liver Disease 42, 1-5.
20. Price RK, Risk NK, Murray KS, Virgo KS, Spitznagel EL (2001). Twenty-five year mortality of US servicemen deployed in Vietnam: predictive utility of early drug use. Drug and Alcohol Dependence 64, 309-318 (Pubitemid 32973874)
21. Prodigy (2005). Guidance for the use of methadone for the treatment of opioid dependence in primary care. In: National Health Service Clinical Knowledge's Summaries. Prodigy. Available at http://cks.library.nhs.uk
22. Sørensen HJ, Jepsen PW, Haastrup S, Juel K (2005). Drug-use pattern, comorbid psychosis and mortality in people with a history of opioid addiction. Acta Psychiatrica Scandinavica 11, 244-249. (Pubitemid 40342193)
23. Tricco AC, Pham B, Brehaut J, Tetroe J, Cappelli M, Hopewell S, Lavis JN, Berlin JA, Moher D (2009). An international survey indicated that unpublished systematic reviews exist. Journal of Clinical Epidemiology 62, 617-623.
24. Wahren CA, Brandt L, Allebeck P (1997). Has mortality in drug addicts increased? A comparison of two hospitalized cohorts in Stockholm. International Journal of Epidemiology 27, 1219-1226. (Pubitemid 28010439)
25. WHO (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Available at http://www.who.int